Does the media prefer DBVT or TKNO?

In the previous week, DBV Technologies had 1 more articles in the media than Alpha Teknova. MarketBeat recorded 2 mentions for DBV Technologies and 1 mentions for Alpha Teknova. DBV Technologies' average media sentiment score of 0.00 equaled Alpha Teknova'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DBV Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Teknova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor SPRY or TKNO?

In the previous week, ARS Pharmaceuticals had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 3 mentions for ARS Pharmaceuticals and 1 mentions for Alpha Teknova. ARS Pharmaceuticals' average media sentiment score of 0.98 beat Alpha Teknova's score of 0.00 indicating that ARS Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ARS Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Teknova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is MGTX or TKNO more profitable?

Alpha Teknova has a net margin of -41.07% compared to MeiraGTx's net margin of -151.12%. Alpha Teknova's return on equity of -24.32% beat MeiraGTx's return on equity. Company Net Margins Return on Equity Return on Assets MeiraGTx -151.12% -1,065.47% -54.96% Alpha Teknova -41.07% -24.32% -16.34%

Does the media prefer MGTX or TKNO?

In the previous week, MeiraGTx had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 3 mentions for MeiraGTx and 1 mentions for Alpha Teknova. MeiraGTx's average media sentiment score of 0.87 beat Alpha Teknova's score of 0.00 indicating that MeiraGTx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MeiraGTx 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alpha Teknova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, EVO or TKNO?

Alpha Teknova has lower revenue, but higher earnings than Evotec. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Evotec $891.97M 1.08 -$117.12M N/A N/A Alpha Teknova $41.80M 6.58 -$17.26M -$0.32 N/A

Is EVO or TKNO more profitable?

Evotec has a net margin of -26.20% compared to Alpha Teknova's net margin of -41.07%. Alpha Teknova's return on equity of -24.32% beat Evotec's return on equity. Company Net Margins Return on Equity Return on Assets Evotec -26.20% -24.93% -11.35% Alpha Teknova -41.07% -24.32% -16.34%

Does the media favor EVO or TKNO?

In the previous week, Evotec and Evotec both had 1 articles in the media. Evotec's average media sentiment score of 0.00 equaled Alpha Teknova'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evotec 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Teknova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is XNCR or TKNO more profitable?

Alpha Teknova has a net margin of -41.07% compared to Xencor's net margin of -177.10%. Alpha Teknova's return on equity of -24.32% beat Xencor's return on equity. Company Net Margins Return on Equity Return on Assets Xencor -177.10% -28.77% -20.52% Alpha Teknova -41.07% -24.32% -16.34%

Does the media favor XNCR or TKNO?

In the previous week, Xencor had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 3 mentions for Xencor and 1 mentions for Alpha Teknova. Xencor's average media sentiment score of 0.50 beat Alpha Teknova's score of 0.00 indicating that Xencor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Xencor 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alpha Teknova 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Alpha Teknova (TKNO) Competitors

$5.13 +0.24 (+4.87%)

As of 12:54 PM Eastern

Compare

TKNO vs. DBVT, SPRY, MGTX, EVO, and XNCR

Should you buy Alpha Teknova stock or one of its competitors? MarketBeat compares Alpha Teknova with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alpha Teknova include DBV Technologies (DBVT), ARS Pharmaceuticals (SPRY), MeiraGTx (MGTX), Evotec (EVO), and Xencor (XNCR). These companies are all part of the "pharmaceutical products" industry.

How does Alpha Teknova compare to DBV Technologies?

DBV Technologies (NASDAQ:DBVT) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

71.7% of DBV Technologies shares are held by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are held by institutional investors. 1.1% of DBV Technologies shares are held by company insiders. Comparatively, 12.5% of Alpha Teknova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, DBV Technologies had 1 more articles in the media than Alpha Teknova. MarketBeat recorded 2 mentions for DBV Technologies and 1 mentions for Alpha Teknova. DBV Technologies' average media sentiment score of 0.00 equaled Alpha Teknova'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DBV Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Teknova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

DBV Technologies presently has a consensus target price of $48.50, indicating a potential upside of 206.48%. Alpha Teknova has a consensus target price of $8.00, indicating a potential upside of 56.01%. Given DBV Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe DBV Technologies is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DBV Technologies	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.88
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

DBV Technologies has a beta of -0.99, indicating that its stock price is 199% less volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market.

Alpha Teknova has higher revenue and earnings than DBV Technologies. Alpha Teknova is trading at a lower price-to-earnings ratio than DBV Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DBV Technologies	$5.64M	166.13	-$146.95M	-$4.46	N/A
Alpha Teknova	$41.80M	6.58	-$17.26M	-$0.32	N/A

Alpha Teknova has a net margin of -41.07% compared to DBV Technologies' net margin of -2,895.37%. Alpha Teknova's return on equity of -24.32% beat DBV Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DBV Technologies	-2,895.37%	-129.88%	-88.84%
Alpha Teknova	-41.07%	-24.32%	-16.34%

Summary

DBV Technologies and Alpha Teknova tied by winning 8 of the 16 factors compared between the two stocks.

How does Alpha Teknova compare to ARS Pharmaceuticals?

ARS Pharmaceuticals (NASDAQ:SPRY) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk, dividends and media sentiment.

In the previous week, ARS Pharmaceuticals had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 3 mentions for ARS Pharmaceuticals and 1 mentions for Alpha Teknova. ARS Pharmaceuticals' average media sentiment score of 0.98 beat Alpha Teknova's score of 0.00 indicating that ARS Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ARS Pharmaceuticals	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Teknova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alpha Teknova has lower revenue, but higher earnings than ARS Pharmaceuticals. Alpha Teknova is trading at a lower price-to-earnings ratio than ARS Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ARS Pharmaceuticals	$98.99M	10.75	-$171.30M	-$2.01	N/A
Alpha Teknova	$41.80M	6.58	-$17.26M	-$0.32	N/A

ARS Pharmaceuticals currently has a consensus target price of $28.60, indicating a potential upside of 167.02%. Alpha Teknova has a consensus target price of $8.00, indicating a potential upside of 56.01%. Given ARS Pharmaceuticals' stronger consensus rating and higher probable upside, equities analysts plainly believe ARS Pharmaceuticals is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ARS Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

68.2% of ARS Pharmaceuticals shares are held by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are held by institutional investors. 33.8% of ARS Pharmaceuticals shares are held by insiders. Comparatively, 12.5% of Alpha Teknova shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Alpha Teknova has a net margin of -41.07% compared to ARS Pharmaceuticals' net margin of -200.00%. Alpha Teknova's return on equity of -24.32% beat ARS Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ARS Pharmaceuticals	-200.00%	-153.61%	-60.85%
Alpha Teknova	-41.07%	-24.32%	-16.34%

ARS Pharmaceuticals has a beta of 0.94, meaning that its stock price is 6% less volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.62, meaning that its stock price is 38% less volatile than the broader market.

Summary

ARS Pharmaceuticals beats Alpha Teknova on 11 of the 17 factors compared between the two stocks.

How does Alpha Teknova compare to MeiraGTx?

MeiraGTx (NASDAQ:MGTX) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

MeiraGTx currently has a consensus price target of $25.83, indicating a potential upside of 116.90%. Alpha Teknova has a consensus price target of $8.00, indicating a potential upside of 56.01%. Given MeiraGTx's stronger consensus rating and higher probable upside, analysts clearly believe MeiraGTx is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MeiraGTx	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.75
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

In the previous week, MeiraGTx had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 3 mentions for MeiraGTx and 1 mentions for Alpha Teknova. MeiraGTx's average media sentiment score of 0.87 beat Alpha Teknova's score of 0.00 indicating that MeiraGTx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MeiraGTx	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Alpha Teknova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

67.5% of MeiraGTx shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 7.4% of MeiraGTx shares are owned by insiders. Comparatively, 12.5% of Alpha Teknova shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Alpha Teknova has lower revenue, but higher earnings than MeiraGTx. Alpha Teknova is trading at a lower price-to-earnings ratio than MeiraGTx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MeiraGTx	$81.39M	13.55	-$114.20M	-$1.48	N/A
Alpha Teknova	$41.80M	6.58	-$17.26M	-$0.32	N/A

MeiraGTx has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

Alpha Teknova has a net margin of -41.07% compared to MeiraGTx's net margin of -151.12%. Alpha Teknova's return on equity of -24.32% beat MeiraGTx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MeiraGTx	-151.12%	-1,065.47%	-54.96%
Alpha Teknova	-41.07%	-24.32%	-16.34%

Summary

MeiraGTx beats Alpha Teknova on 10 of the 16 factors compared between the two stocks.

How does Alpha Teknova compare to Evotec?

Evotec (NASDAQ:EVO) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

In the previous week, Evotec and Evotec both had 1 articles in the media. Evotec's average media sentiment score of 0.00 equaled Alpha Teknova'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Evotec	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Teknova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alpha Teknova has lower revenue, but higher earnings than Evotec.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Evotec	$891.97M	1.08	-$117.12M	N/A	N/A
Alpha Teknova	$41.80M	6.58	-$17.26M	-$0.32	N/A

Evotec has a beta of 1.93, suggesting that its stock price is 93% more volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

5.8% of Evotec shares are owned by institutional investors. Comparatively, 13.8% of Alpha Teknova shares are owned by institutional investors. 12.5% of Alpha Teknova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Evotec has a net margin of -26.20% compared to Alpha Teknova's net margin of -41.07%. Alpha Teknova's return on equity of -24.32% beat Evotec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Evotec	-26.20%	-24.93%	-11.35%
Alpha Teknova	-41.07%	-24.32%	-16.34%

Evotec presently has a consensus price target of $7.00, suggesting a potential upside of 158.30%. Alpha Teknova has a consensus price target of $8.00, suggesting a potential upside of 56.01%. Given Evotec's stronger consensus rating and higher probable upside, equities research analysts plainly believe Evotec is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Evotec	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

Summary

Evotec beats Alpha Teknova on 7 of the 13 factors compared between the two stocks.

How does Alpha Teknova compare to Xencor?

Xencor (NASDAQ:XNCR) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, analyst recommendations, profitability and risk.

Xencor presently has a consensus target price of $24.50, suggesting a potential upside of 67.29%. Alpha Teknova has a consensus target price of $8.00, suggesting a potential upside of 56.01%. Given Xencor's stronger consensus rating and higher possible upside, equities research analysts plainly believe Xencor is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Xencor	2 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40
Alpha Teknova	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

Xencor has a beta of 0.92, suggesting that its share price is 8% less volatile than the broader market. Comparatively, Alpha Teknova has a beta of 0.62, suggesting that its share price is 38% less volatile than the broader market.

Alpha Teknova has a net margin of -41.07% compared to Xencor's net margin of -177.10%. Alpha Teknova's return on equity of -24.32% beat Xencor's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Xencor	-177.10%	-28.77%	-20.52%
Alpha Teknova	-41.07%	-24.32%	-16.34%

Alpha Teknova has lower revenue, but higher earnings than Xencor. Alpha Teknova is trading at a lower price-to-earnings ratio than Xencor, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Xencor	$125.58M	8.65	-$91.92M	-$2.29	N/A
Alpha Teknova	$41.80M	6.58	-$17.26M	-$0.32	N/A

In the previous week, Xencor had 2 more articles in the media than Alpha Teknova. MarketBeat recorded 3 mentions for Xencor and 1 mentions for Alpha Teknova. Xencor's average media sentiment score of 0.50 beat Alpha Teknova's score of 0.00 indicating that Xencor is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Xencor	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alpha Teknova	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

13.8% of Alpha Teknova shares are held by institutional investors. 5.1% of Xencor shares are held by company insiders. Comparatively, 12.5% of Alpha Teknova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Xencor beats Alpha Teknova on 9 of the 17 factors compared between the two stocks.

Get Alpha Teknova News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TKNO vs. The Competition

Export

Metric	Alpha Teknova	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$274.93M	$3.51B	$6.55B	$12.20B
Dividend Yield	N/A	2.30%	2.69%	5.82%
P/E Ratio	-16.03	20.74	25.18	24.19
Price / Sales	6.58	331.77	554.67	122.21
Price / Cash	N/A	128.56	44.82	54.51
Price / Book	4.01	8.37	10.82	6.51
Net Income	-$17.26M	$23.85M	$3.56B	$337.14M
7 Day Performance	3.60%	4.15%	1.98%	0.26%
1 Month Performance	31.83%	3.45%	1.43%	1.22%
1 Year Performance	-4.86%	57.37%	31.13%	28.88%

Alpha Teknova Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TKNO Alpha Teknova	1.7948 of 5 stars	$5.13 +4.9%	$8.00 +56.0%	-7.4%	$274.93M	$41.80M	N/A	240	News Coverage
DBVT DBV Technologies	2.7929 of 5 stars	$16.69 -0.4%	$48.50 +190.7%	+88.2%	$984.27M	N/A	N/A	80	News Coverage
SPRY ARS Pharmaceuticals	3.085 of 5 stars	$9.79 +0.9%	$28.60 +192.1%	-38.0%	$971.55M	$84.28M	N/A	90	News Coverage
MGTX MeiraGTx	3.3421 of 5 stars	$10.15 +4.5%	$25.83 +154.5%	+87.2%	$939.90M	$79.76M	N/A	300
EVO Evotec	1.9368 of 5 stars	$2.61 -3.2%	$7.00 +168.7%	-31.2%	$926.76M	$891.97M	N/A	4,553

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TKNO) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alpha Teknova (TKNO) Competitors

TKNO vs. DBVT, SPRY, MGTX, EVO, and XNCR

How does Alpha Teknova compare to DBV Technologies?

Summary

How does Alpha Teknova compare to ARS Pharmaceuticals?

Summary

How does Alpha Teknova compare to MeiraGTx?

Summary

How does Alpha Teknova compare to Evotec?

Summary

How does Alpha Teknova compare to Xencor?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TKNO vs. The Competition

Alpha Teknova Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alpha Teknova (TKNO) Competitors

TKNO vs. DBVT, SPRY, MGTX, EVO, and XNCR

How does Alpha Teknova compare to DBV Technologies?

Do insiders & institutionals believe in DBVT or TKNO?

Does the media prefer DBVT or TKNO?

Do analysts rate DBVT or TKNO?

Which has more volatility & risk, DBVT or TKNO?

Which has preferable valuation and earnings, DBVT or TKNO?

Is DBVT or TKNO more profitable?

Summary

How does Alpha Teknova compare to ARS Pharmaceuticals?

Does the media favor SPRY or TKNO?

Which has higher earnings & valuation, SPRY or TKNO?

Do analysts prefer SPRY or TKNO?

Do institutionals & insiders believe in SPRY or TKNO?

Is SPRY or TKNO more profitable?

Which has more volatility & risk, SPRY or TKNO?

Summary

How does Alpha Teknova compare to MeiraGTx?

Do analysts prefer MGTX or TKNO?

Does the media prefer MGTX or TKNO?

Do institutionals and insiders believe in MGTX or TKNO?

Which has better earnings & valuation, MGTX or TKNO?

Which has more volatility and risk, MGTX or TKNO?

Is MGTX or TKNO more profitable?

Summary

How does Alpha Teknova compare to Evotec?

Does the media favor EVO or TKNO?

Which has stronger earnings and valuation, EVO or TKNO?

Which has more volatility and risk, EVO or TKNO?

Do institutionals & insiders hold more shares of EVO or TKNO?

Is EVO or TKNO more profitable?

Do analysts recommend EVO or TKNO?

Summary

How does Alpha Teknova compare to Xencor?

Do analysts prefer XNCR or TKNO?

Which has more risk and volatility, XNCR or TKNO?

Is XNCR or TKNO more profitable?

Which has stronger valuation & earnings, XNCR or TKNO?

Does the media favor XNCR or TKNO?

Do insiders & institutionals have more ownership in XNCR or TKNO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TKNO vs. The Competition

Alpha Teknova Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools